Scandium43QualityChecker

Scandium-43

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity PET
Open selection

Utility description: Scandium-43

Scandium-43 Quality Checker — Scandium-43 for PET Imaging (Theranostics)

ℹ️  Utility checks critical parameters of Scandium-43:
    • Radionuclidic purity (≥99.0%)
    • Scandium-44 impurity (≤1.0%)
    • Scandium-46 impurity (≤0.1%)
    • Radiochemical purity (≥95%, DOTA/NOTA complex)
    • Free Scandium (≤5%)
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Scandium-43 is the ideal partner for Scandium-47 (therapy).
    Sc-44 impurity degrades PET image quality due to high-energy gamma quanta.

Usage:
  Scandium43QualityChecker.exe                            → demo mode (console output)
  Scandium43QualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Scandium44ImpurityPercent,Scandium46ImpurityPercent,RadiochemicalPurityPercent,FreeScandiumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
  SC43-DOTA-2026-001,200.0,99.5,0.4,0.01,98.0,2.0,5.5,30.0,0,2,DOTA-Peptide

Supported product types:
• DOTA-Peptide — peptides for neuroendocrine tumor imaging
• NOTA-Antibody — antibodies for immuno-PET
• FreeIon — biodistribution studies

— WHY IS THIS NEEDED?
Scandium-43 (T½=3.89 h) is a promising positron-emitting isotope for PET:
• Ideal theranostic pair with Scandium-47 (beta-emitter, T½=3.35 d)
• Chemically identical to Sc-47, ensuring identical biodistribution for diagnostic and therapeutic doses
• Positron energy E_max=1.2 MeV provides good image resolution
• Produced in cyclotron (Ca-43 proton irradiation) or from Ti-44/Sc-43 generator

⚠️  CRITICAL:
• Radionuclidic purity ≥99.0% — presence of other scandium isotopes is unacceptable.
• Scandium-44 (T½=3.97 h) impurity ≤1.0% — Sc-44 often co-produces. It emits high-energy gamma quanta (1157 keV), creating noise in PET images and increasing patient dose without diagnostic benefit.
• Scandium-46 (T½=83.8 d) impurity ≤0.1% — Long-lived impurity, creating radioactive waste issues and long-term irradiation.
• Radiochemical purity ≥95% — Scandium forms very stable complexes with macrocyclic chelators (DOTA, NOTA). High RCP ensures in vivo stability.
• Free Scandium ≤5% — Ionic scandium accumulates in liver and bones, distorting images and increasing dose to these organs.
• Heavy metals ≤10 ppm — Metal ions (Fe, Zn, Cu) compete with scandium for chelator binding sites, reducing labeling yield.
• pH 4.5–7.5, Endotoxins ≤175 EU/vial, Sterility — standard safety requirements.

Key features:
• Control of specific scandium isotopic impurities (Sc-44, Sc-46)
• Assessment of suitability for theranostic application (pair with Sc-47)
• Heavy metal control, critical for labeling efficiency
• Support for various bioconjugates (peptides, antibodies)

Critical parameters:
• Radionuclidic purity: ≥99.0%
• Sc-44 impurity: ≤1.0%
• Sc-46 impurity: ≤0.1%
• Radiochemical purity: ≥95.0%
• Free Scandium: ≤5.0%
• Heavy metals: ≤10 ppm
• pH: 4.5–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth

💡 Usage tips:
1. Separation of Sc-43 and Sc-44 requires mass separation or careful selection of proton beam energy during production.
2. Labeling DOTA-peptides requires heating (95°C, 15-20 min), NOTA-conjugates can be labeled at room temperature or mild heating.
3. Presence of heavy metals in buffer or precursor sharply reduces specific activity. Use ultra-pure reagents.
4. Sc-43 is ideal for imaging processes with intermediate kinetics (peptides, small proteins).

⚠️ Note: Scandium-43 represents the "gold standard" of theranostics within a single element. Unlike Ga-68/Lu-177 pairs, where gallium and lutetium chemistry differs, scandium isotopes are chemically identical. This means diagnostic scan with Sc-43 accurately predicts distribution of therapeutic Sc-47. However, Sc-44 impurity is the main technical challenge in cyclotron production.

input.csv

BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Scandium44ImpurityPercent,Scandium46ImpurityPercent,RadiochemicalPurityPercent,FreeScandiumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
SC43-DOTA-2026-001,200.0,99.5,0.4,0.01,98.0,2.0,5.5,30.0,0,2,DOTA-Peptide
SC43-NOTA-2026-002,150.0,98.0,1.5,0.05,96.0,4.0,6.0,50.0,0,5,NOTA-Antibody
SC43-FAIL-2026-003,180.0,95.0,4.0,0.5,90.0,10.0,4.0,200.0,0,15,DOTA-Peptide

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Scandium43QualityChecker for Scandium-43.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Scandium-43:
  • • Radionuclidic purity (≥99.0%)
  • • Scandium-44 impurity (≤1.0%)
  • • Scandium-46 impurity (≤0.1%)
  • • Radiochemical purity (≥95%, DOTA/NOTA complex)
  • • Free Scandium (≤5%)
  • • pH, endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Scandium-43 is the ideal partner for Scandium-47 (therapy).
  • Sc-44 impurity degrades PET image quality due to high-energy gamma quanta.
  • BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Scandium44ImpurityPercent,Scandium46ImpurityPercent,RadiochemicalPurityPercent,FreeScandiumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
  • Example (sterility: 0=sterile, 1=contaminated):
  • • FreeIon — biodistribution studies
  • ⚠️ CRITICAL:
  • • Radionuclidic purity ≥99.0% — presence of other scandium isotopes is unacceptable.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Scandium-43 using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringSC43-DOTA-2026-001Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal200.0Radioactivity value used for release, decay or dose-related assessment.
3RadionuclidicPurityPercentstring99.5Radionuclidic purity; a critical radiation-safety and impurity parameter.
4Scandium44ImpurityPercentstring0.4Controlled impurity or residual material.
5Scandium46ImpurityPercentstring0.01Controlled impurity or residual material.
6RadiochemicalPurityPercentstring98.0Radiochemical purity; confirms the labelled chemical form and binding quality.
7FreeScandiumPercentdecimal2.0Free radionuclide / unbound species; important for non-target uptake and toxicity.
8pHdecimal5.5Solution pH; relevant for stability, compatibility and administration.
9EndotoxinsEUdecimal30.0Bacterial endotoxins; critical for parenteral administration.
10SterilityTestflag / boolean0Sterility result; critical release parameter.
11HeavyMetalsPPMdecimal2Elemental impurity / metal residue parameter.
12ProductTypestringDOTA-PeptideControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Scandium44ImpurityPercent,Scandium46ImpurityPercent,RadiochemicalPurityPercent,FreeScandiumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
SC43-DOTA-2026-001,200.0,99.5,0.4,0.01,98.0,2.0,5.5,30.0,0,2,DOTA-Peptide
SC43-NOTA-2026-002,150.0,98.0,1.5,0.05,96.0,4.0,6.0,50.0,0,5,NOTA-Antibody
SC43-FAIL-2026-003,180.0,95.0,4.0,0.5,90.0,10.0,4.0,200.0,0,15,DOTA-Peptide

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Scandium-43, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "scandium43-quality-checker",
  "api": "Scandium-43",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "SC43-DOTA-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "200.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Scandium44ImpurityPercent",
      "value": "0.4",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Scandium46ImpurityPercent",
      "value": "0.01",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeScandiumPercent",
      "value": "2.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "5.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: Ga/Ge

Ga-67, Ga-68 and Ge-68: generator, radiolabelling, PET/SPECT and purity workflows.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: PET/SPECT oncology diagnostics and receptor imaging

F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open